Atlas Trials

Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)

Clinical trial NCT05193591 · RECRUITING

Trial details

NCT number
NCT05193591
Sponsor
University Hospital, Grenoble
Status
RECRUITING
Study type
OBSERVATIONAL
Lupus Erythematosus, Systemic
Start date
2022-03-11
Primary completion
2025-09-10
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.